Key result
Intravenous administration of adenosine for supraventricular tachycardia induced a rare, transient second-degree Mobitz type 2 sinoatrial node exit block.
Case Report (n=1)
No
This case highlights a rare and previously unreported side effect of adenosine—second-degree type 2 sinoatrial node exit block—emphasizing the need for careful monitoring during its administration.
Answers are grounded in this paper and cite their sources.
Requires vigilance for rare sinoatrial block with adenosine; case report extends adverse-event spectrum but leaves incidence open.
Adenosine is a widely used pharmacologic agent in the field of cardiology, predominantly for the termination of supraventricular tachycardias and diagnostic purposes. Most of the side effects are short-lasting due to its very short half-life. Fatal complications of adenosine are rare but can include ventricular fibrillation, ventricular tachycardia, and asystole. Proper medical supervision and monitoring are crucial to minimize risks. We report a unique case of a second-degree type 2 sinoatrial node exit block following intravenous adenosine administration in a 25-year-old male presenting with palpitations.
No takes yet. Share an insight, caveat, or question.
Mahanta et al. (2024) conducted a case report in Supraventricular tachycardia (n=1). Adenosine was evaluated on Development of second-degree type 2 sinoatrial node exit block. Intravenous administration of adenosine for supraventricular tachycardia induced a rare, transient second-degree Mobitz type 2 sinoatrial node exit block.
Synapse has enriched 10 related papers. Consider them for comparative context: